J9217 – Leuprolide acetate (for depot suspension), 7.5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9217
- Long description
- Leuprolide acetate (for depot suspension), 7.5 mg
- Short description
- Leuprolide acetate suspnsion
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 1991
- Last change
- January 1, 1997 – No change
Frequently asked questions
What is HCPCS code J9217?
J9217 is a HCPCS Level II code for leuprolide acetate (for depot suspension), 7.5 mg.
Does Medicare cover J9217?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9209 – Injection, mesna, 200 mg
- J9210 – Injection, emapalumab-lzsg, 1 mg
- J9211 – Injection, idarubicin hydrochloride, 5 mg
- J9212 – Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213 – Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214 – Injection, interferon, alfa-2b, recombinant, 1 million units
- J9215 – Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
- J9216 – Injection, interferon, gamma 1-b, 3 million units
- J9218 – Leuprolide acetate, per 1 mg
- J9219 – Leuprolide acetate implant, 65 mg
- J9220 – Injection, indigotindisulfonate sodium, 1 mg
- J9223 – Injection, lurbinectedin, 0.1 mg
- J9225 – Histrelin implant (vantas), 50 mg
- J9226 – Histrelin implant (supprelin la), 50 mg
- J9227 – Injection, isatuximab-irfc, 10 mg
- J9228 – Injection, ipilimumab, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.